Massachusetts Financial Services’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Massachusetts Financial Services’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50,026	Closed	-$2.2M	–	948
2021 Q2	$2.2M	Sell	50,026 -148	-0.3%	-$8.24K	﹤0.01%	771
2021 Q1	$3.64M	Sell	50,174 -1,206	-2%	-$85.7K	﹤0.01%	714
2020 Q4	$2.22M	Buy	51,380 +949	+2%	+$42.5K	﹤0.01%	725
2020 Q3	$2.07M	Sell	50,431 -1,239	-2%	-$64K	﹤0.01%	712
2020 Q2	$3.1M	Buy	51,670 +1,831	+4%	+$168K	﹤0.01%	654
2020 Q1	$3.75M	Sell	49,839 -1,159	-2%	-$133K	﹤0.01%	644
2019 Q4	$7.01M	Buy	50,998 +15	+0%	+$1.82K	﹤0.01%	625
2019 Q3	$6.06M	Sell	50,983 -197	-0.4%	-$27.5K	﹤0.01%	644
2019 Q2	$7.16M	Buy	51,180 +7,038	+16%	+$1.24M	﹤0.01%	647
2019 Q1	$7.89M	Sell	44,142 -30	-0.1%	-$4.51K	﹤0.01%	631
2018 Q4	$6.95M	Buy	+44,172	New	+$6.59M	﹤0.01%	639

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Massachusetts Financial Services's ORTX Position: Q3 2021 in Review

Massachusetts Financial Services sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 50,026 shares — an estimated $2.2M sold.

Massachusetts Financial Services first reported a position in ORTX in Q4 2018 and held it in 11 quarters. The position peaked at $7.89M in Q1 2019. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

Massachusetts Financial Services reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Massachusetts Financial Services sold 50,026 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $2.2M.
Massachusetts Financial Services first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 11 quarters.
Massachusetts Financial Services's Orchard Therapeutics plc American Depositary Shares position peaked at $7.89M in Q1 2019.
79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Massachusetts Financial Services's 13F filing for Q3 2021, filed 10 Nov 2021.